rais question whether competit drive
pressur custom proof stabil
least month away expect pressur stock pt
unexpect price pressur emerg work suggest
path competitor impact algn growth expect
impact near-term consid competitor commentari indic
unwilling discount particularli earli stage launch
cover josh pokrzywinski outsid us
success smiledirectclub sdc dtc clear align anoth known
threat view sdc overlap case nomin left us
think impact also unlik event disclosur
saw acceler price pressur expect persist
rais question whether dynam alreadi put pressur
franchis indic price pressur result mix shift
lower price product launch unexpectedli rapid uptak
new volum incent program higher volum custom challeng
investor reconcil algn view competit
dynam play algn histori execut promot
product launch without signific price disrupt part attempt
take middle-of-the-road approach advanc inform
lower pt impli upsid opportun remain
vast volum growth rapid proof point price requir stock
out-performance sever month away
oper environ tougher see sharp chang
certainli challeng environ could drive price
sensit among algn custom competit launch four major us
player competit updat acquisit clearcorrect
stmn cover michael jungl like elev custom interest
price though product truli substitut algn function
player overtli discount high low end
barbel product line offer present wider array
product tier could allow custom address subset case
medic technolog unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
lower price point select product best suit particular case
complex separ clinician awar emerg dtc orthodont
player smiledirectclub sdc reportedli annual case per
year roughli algn volum year market
price case discount custom level rel treatment
dentist/orthodontist indic sdc case overlap roughli
case though sdc recent capit rais would posit
compani continu innov toward higher complex case sdc case
last averag month believ averag case last closer
year risk contempl downgrad
downgrad ew valuat slow lead indic neither truli
new step chang accord dilig leav explan
price somewhat tie tactic price/promot error
number volum line concern volum continu
track strongli estim acceler growth revenu
growth compress vs guidanc call
deceler three-year low driven expect on-going asp
pressur slower scanner/itero sale spite termin
promot program pressur clear align
q/q yr/yr reflect combin fx true asp eros higher
fix cost expand manufactur guidanc call anoth qr/qr
step expand manufactur spend drive less
chang leav focu squar
stock lower pt correspond
reduct ep estim make chang target
yield methodolog roll forward valuat year end
compani coverag earn near term expect
market question structur barrier entri support algn
growth assign lower multipl given algn volum growth remain
robust direct evid competitor activ chang
structur market prefer wait signific chang
pend dilig near term investor may choos valu
recent trough multipl ep figur presum meaning
improv ebit growth rel could support valuat
averag ep expect dilig near term
find littl evid true competit pressur revenu
estim go lower ep estim go lower
strong market augment distribut major competitor emerg
macro trend improv expect us europ at-hom
align market grow fast predic aesthet market key
beneficiari share
underli trend improv top-line growth moder
tough comp align abl retain key share among high-
volum ortho north america increas digit
intern sale continu grow clip medium term ep
growth compound-annual-growth-rate captur emerg at-hom align
opportun
competit littl tougher macro environ slow
aggress promot competit product activ us europ
us high-end spend growth stabil recoveri post-crisi
investor turn attent ip expir npv impact
addit competit at-hom align opportun emerg slowli
captur share
invisalign growth expect continu
assum increment competit despit
potenti entrant near term
new featur market support
differenti barrier entri
consum sensit remain high
invisalign typic target toward case
discretionari
interoper intraor scanner
includ siro omnicam expand
potenti custom base
appear like key beneficiari
emerg at-hom align opportun
could size core
invisalign consum appeal substanti
clear align far less disrupt
patient activ tradit brace
align offer wide array featur set
orient vari degre physician
profici patient age case sever
increas mix digit case submiss
current orthodont total
time half
inflect discretionari spend
local facil salesforc emea
apac
risk achiev price
spend us abroad
new competit entri aggress
price
loss tax deduct
exhibit case volum growth acceler new high
yr-yr chang shipment
yr-yr chang us
number custom order
exhibit revenu growth rel profit growth
revenu oper profit trend
exhibit chang forecast
sale
sale
sale
sale
sale
sale
million except ep
scanner servic
compani data morgan stanley research
valuat risk
exhibit ev/sal valuat vs fast growth compani
thomson reuter morgan stanley research
thomson reuter morgan stanley research
thomson reuter morgan stanley research
thomson reuter morgan stanley research
thomson reuter morgan stanley research
thomson reuter morgan stanley research
price target price base yield
estim impli price-to-earnings multipl discount current multipl
ntm price-to-earnings see acceler ep growth ep compound-annual-growth-rate
rang busi reap benefit agreement sdc
increas digit technolog among dentist intern market penetr
risk price target includ discretionari consum spend trend
competit entri market
compani data morgan stanley research
compani data morgan stanley research
